Genetec Management

Management criteria checks 1/4

Genetec's CEO is Kenji Ueno, appointed in Jul 1985, has a tenure of 38.83 years. directly owns 45.7% of the company’s shares, worth ¥3.72B. The average tenure of the management team and the board of directors is 2.1 years and 2.9 years respectively.

Key information

Kenji Ueno

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	38.8yrs
CEO ownership	45.7%
Management average tenure	2.1yrs
Board average tenure	2.9yrs

Recent management updates

Recent updates

Genetec Corporation (TSE:4492) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected

Feb 26

Capital Allocation Trends At Genetec (TYO:4492) Aren't Ideal

Mar 28

Genetec Corporation (TYO:4492) Has A ROE Of 13%

Nov 23

CEO

Kenji Ueno (73 yo)

38.8yrs

Tenure

Mr. Kenji Ueno serves as the President, Chairman of Board & Representative Director at Genetec Corporation since July 1985. He serves as Chief Executive Officer at Genetec Corporation.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kenji Ueno	President	38.8yrs	no data	45.7% ¥ 3.7b
Akihiro Suzuki	Managing Executive Officer	2.9yrs	no data	0.21% ¥ 17.1m
Chia Matsuno	Senior Executive Officer	1.3yrs	no data	no data
Eiji Shimba	Executive Officer	no data	no data	no data
Tetsuya Iyo	Executive Officer	no data	no data	no data
Takashi Ogawa	Executive Officer	no data	no data	no data
Katsuji Shibasaki	Executive Officer	1.3yrs	no data	no data

2.1yrs

Average Tenure

61yo

Average Age

Experienced Management: 4492's management team is considered experienced (2.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kenji Ueno	President	38.8yrs	no data	45.7% ¥ 3.7b
Akihiro Suzuki	Managing Executive Officer	2.9yrs	no data	0.21% ¥ 17.1m
Chia Matsuno	Senior Executive Officer	less than a year	no data	no data
Masatoshi Hachinohe	Director	9.3yrs	no data	2.63% ¥ 214.2m
Midori Mizutani	Independent Outside Director	2.9yrs	no data	no data
Shunpei Tanaka	Independent Outside Director	2.9yrs	no data	no data
Hiroyoshi Shirakami	Independent Outside Director	1.9yrs	no data	no data

2.9yrs

Average Tenure

61yo

Average Age

Experienced Board: 4492's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Genetec Management

Management criteria checks 1/4

Key information

Recent management updates

Genetec Corporation, Annual General Meeting, Jun 25, 2024

Less than half of directors are independent

Genetec Corporation, Annual General Meeting, Jun 28, 2022

No independent directors

Recent updates

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Genetec Corporation, Annual General Meeting, Jun 25, 2024

Investor sentiment deteriorates as stock falls 21%

Genetec Corporation to Report Fiscal Year 2024 Results on May 15, 2024

Upcoming dividend of JP¥6.50 per share

Genetec Corporation (TSE:4492) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected

Third quarter 2024 earnings released

Investor sentiment improves as stock rises 18%

New major risk - Share price stability

Investor sentiment improves as stock rises 20%

New major risk - Share price stability

Genetec Corporation to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released

Investor sentiment improves as stock rises 25%

Genetec Corporation to Report Q2, 2024 Results on Nov 14, 2023

First quarter 2024 earnings released: JP¥5.02 loss per share (vs JP¥34.94 loss in 1Q 2023)

Genetec Corporation to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of JP¥10.00 per share at 2.0% yield

Third quarter 2023 earnings released: JP¥13.22 loss per share (vs JP¥1.87 loss in 3Q 2022)

Genetec Corporation (TSE:4492) agreed to acquire Topwell Co., Ltd. from Yasuhide Inoue for ¥547 million.

Genetec Corporation to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released

Less than half of directors are independent

Genetec Corporation to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: JP¥34.94 loss per share (vs JP¥19.20 profit in 1Q 2022)

Genetec Corporation to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Genetec Corporation, Annual General Meeting, Jun 28, 2022

No independent directors

Genetec Corporation to Report Fiscal Year 2022 Results on May 16, 2022

Upcoming dividend of JP¥10.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Genetec Corporation (JASDAQ:4492) agreed to acquire BART Co., Ltd. from Hitoshi Fujita and others.

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JP¥4.02 (vs JP¥8.13 in 2Q 2021)

Upcoming dividend of JP¥4.00 per share

Investor sentiment deteriorated over the past week

Full year 2021 earnings released: EPS JP¥94.39 (vs JP¥141 in FY 2020)

Capital Allocation Trends At Genetec (TYO:4492) Aren't Ideal

Upcoming dividend of JP¥8.00 per share

New 90-day low: JP¥1,846

New 90-day low: JP¥1,926

Genetec Corporation (TYO:4492) Has A ROE Of 13%

New 90-day high: JP¥2,421

New 90-day low - JP¥1,542

Genetec Corporation to Report Q1, 2021 Results on Aug 05, 2020

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age